Investor Relations
Jan 07, 2019
OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories MORE >>
Dec 27, 2018
OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, Announce Proposed Resolution of SEC Action MORE >>
Nov 09, 2018
OPKO Health Reports Third Quarter 2018 Financial Results MORE >>
Nov 08, 2018
BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services MORE >>

SEC Filings

Form Description Filing date View
10QSB

Quarterly report filed by small businesses

View HTML
SB-2/A

Pre-effective amendment to an SB-2 filing

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
SB-2

Optional form for the registration of securities to be sold to the public by small business issuers

View HTML
10QSB

Quarterly report filed by small businesses

View HTML
10KSB40

Optional form for annual and transition reports of small business issuers

View HTML
S-3

Simplified registration form

View HTML
POS AM

Post-effective amendment to an S-Type filing

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML